These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 27385098)
41. The expression of neurotrophins and their receptors in the prenatal and adult human testis: evidence for functions in Leydig cells. Müller D; Davidoff MS; Bargheer O; Paust HJ; Pusch W; Koeva Y; Jezek D; Holstein AF; Middendorff R Histochem Cell Biol; 2006 Aug; 126(2):199-211. PubMed ID: 16463180 [TBL] [Abstract][Full Text] [Related]
42. Neurotrophin system activation in pleural effusions. Ricci A; Mariotta S; Pompili E; Mancini R; Bronzetti E; De Vitis C; Pisani L; Cherubini E; Bruno P; Gencarelli G; Giovagnoli MR; Terzano C; Ciliberto G; Giarnieri E; Fumagalli L Growth Factors; 2010 Aug; 28(4):221-31. PubMed ID: 20214505 [TBL] [Abstract][Full Text] [Related]
43. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism. Raimondo S; Saieva L; Corrado C; Fontana S; Flugy A; Rizzo A; De Leo G; Alessandro R Cell Commun Signal; 2015 Feb; 13():8. PubMed ID: 25644060 [TBL] [Abstract][Full Text] [Related]
44. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078 [TBL] [Abstract][Full Text] [Related]
45. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Junker N; Johansen JS; Hansen LT; Lund EL; Kristjansen PE Cancer Sci; 2005 Mar; 96(3):183-90. PubMed ID: 15771622 [TBL] [Abstract][Full Text] [Related]
46. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line. Akiyama Y; Ashizawa T; Komiyama M; Miyata H; Oshita C; Omiya M; Iizuka A; Kume A; Sugino T; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K Oncol Rep; 2014 Jul; 32(1):159-66. PubMed ID: 24842123 [TBL] [Abstract][Full Text] [Related]
47. Mesenchymal/proangiogenic factor YKL-40 related to glioblastomas and its relationship with the subventricular zone. Batista KMP; Eulate-Beramendi SA; Pińa KYÁR; Figueira PR; Canal AF; Chasin JMA; Meilan Á; Ugalde R; Vega IF Folia Neuropathol; 2017; 55(1):14-22. PubMed ID: 28430288 [No Abstract] [Full Text] [Related]
48. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients. Salvati M; Pichierri A; Piccirilli M; Floriana Brunetto GM; D'Elia A; Artizzu S; Santoro F; Arcella A; Giangaspero F; Frati A; Simione L; Santoro A J Neurosurg; 2012 Aug; 117(2):204-11. PubMed ID: 22655594 [TBL] [Abstract][Full Text] [Related]
49. MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis. Yang CH; Wang Y; Sims M; Cai C; He P; Yue J; Cheng J; Boop FA; Pfeffer SR; Pfeffer LM Oncotarget; 2016 Dec; 7(51):84017-84029. PubMed ID: 27705947 [TBL] [Abstract][Full Text] [Related]